SESSION IV

GASTROINTESTINAL SURGERY TO TREAT DIABETES IN PATIENTS WHO ARE NOT SEVERELY OBESE
(BMI <35) (3:05 – 4:45 pm)


Session Chair
Walter J. Pories (USA)

Program Committee
Ricardo Cohen (Brazil)
Geltrude Mingrone (Italy)

Objectives
• To present experimental data about diabetes control after gastrointestinal procedures in obese and non-obese animals
• To present diabetes and metabolic outcomes of conventional bariatric operations and novel surgical procedures in patients with BMI <35
• To discuss the relationships between body weight and Type 2 diabetes
• To discuss why the unigender, uniracial BMI may not be a reliable or appropriate indicator for the surgical treatment of diabetes
• To discuss alternative parameters for the definition of risk/benefit in diabetes surgery

Keynote Lectures
• The BMI: The Good and the Bad: The Relationship of Body Weight to Glucose Metabolism- Scott Going (USA)
• Conventional, Bariatric and Novel Gastrointestinal Procedures in Patients with BMI <35 (Roux-en-Y Gastrectomy, Billroth II, RYGB, BPD, DJB, Gastric Banding, Sleeve Gastrectomy, Ileal Interposition and Combination Procedures)- Francesco Rubino (USA)

Panel Discussion
What reliable alternative to BMI cut-offs could be used to indicate surgical treatment? What is the ideal operation for mildly obese or overweight patients? What ethical guidelines should govern the application of new procedures and what types of clinical trials should be pursued?

Moderators
Walter Pories (USA)
Bernard Zinman (Canada)

Panelists
Ross Brechner (CMS-USA)
Ricardo Cohen (Brazil)
John Dixon (Australia)
Lynis Dohm (USA)
Michel Gagner (USA)
Desmond Johnston (UK)
Takashi Kadowaki (Japan)
Geltrude Mingrone (Italy)